Put companies on watchlist
Symrise AG
ISIN: DE000SYM9999
WKN: SYM999
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Symrise AG · ISIN: DE000SYM9999 · EQS - Company News (47 News)
Country: Germany · Primary market: Germany · EQS NID: 1212925
29 June 2021 08:00AM

Symrise to invest in Swedish pet health products provider Swedencare


DGAP-News: Symrise AG / Key word(s): Investment
Symrise to invest in Swedish pet health products provider Swedencare

29.06.2021 / 08:00
The issuer is solely responsible for the content of this announcement.


 

  • Strategic investment of 5 % in Swedencare's capital through acquisition of new shares
  • Strong opportunity for collaboration and exploration of additional growth activities in the highly dynamic global pet food market
 

Symrise AG today announced that it has agreed to make a strategic investment in Swedencare, a fast-growing provider of premium pet health products. With this step Symrise underpins its leading position as a provider of innovative solutions and applications for pet food. The investment will be made as part of a capital increase of Swedencare and takes place in full consent with the company and its management team. In total Symrise will acquire 5.06 % of the share capital in Swedencare.

"We look forward to becoming a strategic shareholder in Swedencare and to support the fast-growing business. Swedencare is an impressive company that shares our passion for pet food solutions. In many markets the trend to pet ownership is increasing significantly and owners choose to provide their pets with products that best possibly support their health conditions," said Dr. Heinz Jürgen Bertram, CEO of Symrise AG. "Swedencare has built a highly profitable business with a diverse portfolio and international presence. Our companies share many similarities and run complementary activities. We see a lot of opportunities to jointly strengthen our competencies. Symrise therefore underlines its commitment with an investment in Swedencare."

Headquartered in Malmö and listed on the Nasdaq First North Growth Market in Stockholm, Swedencare offers premium products on the global and fast-growing market of healthcare products for cats, dogs and horses. The product portfolio includes an innovative all-natural dietary supplement for oral care which is patented in more than 30 countries as well as a broad range of grooming products for pets and dietary supplements in several other areas, such as joints and mobility. Swedencare sells its products across fifty markets globally, distributed via veterinarians and pet stores. In addition, the company runs an international online distributions network. Since going public in 2016, Swedencare has expanded its activities through both, organic growth and build on acquisitions. Swedencare's sales for the twelve months April 2020 - March 2021 were 336 million SEK (approx. €32 Mio.) with an EBITDA of 96 million SEK (approx. €9 Mio.), corresponding to an EBITDA-margin of 28,5%. Swedencare currently employs approx. 100 people across seven countries worldwide.

Symrise is a global leader in the pet food industry. The Group is capitalizing on its profound knowhow in sensorial and functional ingredients to improve palatability and develop solutions with positive effects on cardiovascular and cognitive health. With its multifaceted activities and profound knowhow in oral care Symrise sees a range of possibilities to jointly explore additional growth opportunities together with Swedencare.

Håkan Lagerberg, CEO of Swedencare, said: "We welcome Symrise as a new strategic investor and regard their engagement as a confirmation of our business and growth strategy. We are convinced that we can benefit from Symrise's profound expertise in R&D and the pet food market."

About Swedencare:

Swedencare, a listed company on NASDAQ First North Growth Market, is specialized in pet healthcare and produces partly in own factories, markets and sells premium products on the global and fast-growing market. The company has a wide range of strong brands and products within most therapy areas, which includes, to mention some, Animal Pharmaceuticals(R), nutravet(R), NutriScience, PetMD(R), Stratford(R), VetWELL(R) as well as ProDen PlaqueOff(R) for oral health to dogs and cats. Swedencare's headquarter is situated in Malmö, Sweden with twelve subsidiaries located in seven countries.

About Symrise:

Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of € 3.5 billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise - always inspiring more .

www.symrise.com

 

Media contact:
 
Investor contact:
Bernhard Kott Tobias Erfurth
Phone: +49 (0)5531 90-1721 Phone: +49 (0)5531 90-1879
Email: bernhard.kott@symrise.com Email: tobias.erfurth@symrise.com
   
Social media:  
twitter.com/symriseag linkedin.com/company/symrise
youtube.com/agsymrise xing.com/companies/symrise
instagram.com/symriseag  
 

 



29.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail: ir@symrise.com
Internet: www.symrise.com
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1212925

 
End of News DGAP News Service

1212925  29.06.2021 

fncls.ssp?fn=show_t_gif&application_id=1212925&application_name=news&site_id=boersengefluester_html
Visual performance / price development - Symrise AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.